Pulmonary hypertension: aortic and/or mitral valve surgery performed via a minimally invasive approach


Pulmonary hypertension ( PH ) in the setting of left-sided valvular heart disease is common, and significantly increases the risk of perioperative morbidity and mortality in patients undergoing aortic and/or mitral valve surgery.

Minimally invasive valve surgery is associated with a decreased incidence of perioperative complications, and a faster recovery, when compared with conventional sternotomy.

In a study, the outcomes of 569 patients with pulmonary hypertension who underwent minimally invasive aortic and/or mitral valve surgery were analysed.

The operative mortality was 3.5%, and postoperative strokes occurred in 1.4%.

The mean intensive care unit and hospital length of stays were 50 ± 14 h and 7 ± 1 days, respectively.

Patients with severe PH ( mean pulmonary artery pressure greater than or equal to 40 mmHg ) had a longer duration of postoperative ventilation and intensive care unit length of stay, when compared with mild / moderate pulmonary hypertension, and similar clinical outcomes.

In conclusion, a minimally invasive approach to aortic and/or mitral valve surgery in patients with pulmonary hypertension is safe and feasible, and may be considered as an alternative to conventional median sternotomy. ( Xagena )

Gosain P et al, Interact Cardiovasc Thorac Surg 2016; Epub ahead of print

XagenaMedicine_2016



Indietro

Altri articoli

Full positive results from the HELIOS-A phase 3 study of Vutrisiran, an investigational RNAi therapeutic in development for the treatment...


The FDA ( Food and Drug Administration ) has expanded the approved use of the CoreValve System to treat certain...


The FDA ( Food and Drug Administration ) has approved of the self-expanding transcatheter CoreValve System for severe aortic stenosis...


Alkaptonuria ( AKU ) is a rare inherited metabolic disorder with severe premature spondyloarthropathy as a major manifestation. Although joint...


Bicuspid aortic valve ( BAV ) is the most frequent congenital heart disease with frequent involvement in thoracic aortic dilatation,...


Pallister-Killian syndrome ( PKS ) is a sporadic multisystem genetic diagnosis characterized by facial dysmorphia, variable developmental delay and intellectual...


A newly identified genetic variant doubles the risk of calcium buildup in the heart’s aortic valve. Calcium buildup is the...


Alkaptonuria is caused by deficiency of homogentisate 1,2-dioxygenase, an enzyme that converts homogentisic acid ( HGA ) to maleylacetoacetic acid...


The SEAS ( Simvastatin and Ezetimibe in Aortic Stenosis ) study has investigated the effects of intensive cholesterol lowering with...